» Articles » PMID: 12149189

Dangerous Liaisons: the Role of "danger" Signals in the Immune Response to Gene Therapy

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2002 Aug 1
PMID 12149189
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Recent studies in gene transfer suggest that the innate immune system plays a significant role in impeding gene therapy. In this review, we examine factors that might influence the recruitment and activation of the innate system in the context of gene therapy. We have adopted a novel model of immunology that contends that the immune system distinguishes not between self and nonself, but between what is dangerous and what is not dangerous. In taking this perspective, we provide an alternative and complementary insight into some of the failures and successes of current gene therapy protocols.

Citing Articles

Macrophage Inhibitor Clodronate Enhances Liver Transduction of Lentiviral but Not Adeno-Associated Viral Vectors or mRNA Lipid Nanoparticles in Neonatal and Juvenile Mice.

Touramanidou L, Gurung S, Cozmescu C, Perocheau D, Moulding D, Finn P Cells. 2024; 13(23).

PMID: 39682727 PMC: 11640373. DOI: 10.3390/cells13231979.


Modification of the tumor microenvironment enhances immunity with plasmid gene therapy.

Shi G, Synowiec J, Singh J, Heller R Cancer Gene Ther. 2024; 31(4):641-648.

PMID: 38337037 PMC: 11702831. DOI: 10.1038/s41417-024-00728-0.


Transcriptional Targeting and MicroRNA Regulation of Lentiviral Vectors.

Merlin S, Follenzi A Mol Ther Methods Clin Dev. 2019; 12:223-232.

PMID: 30775404 PMC: 6365353. DOI: 10.1016/j.omtm.2018.12.013.


Modulation of immune responses in lentiviral vector-mediated gene transfer.

Annoni A, Gregori S, Naldini L, Cantore A Cell Immunol. 2018; 342:103802.

PMID: 29735164 PMC: 6695505. DOI: 10.1016/j.cellimm.2018.04.012.


Hemophilia A: an ideal disease to correct in utero.

Porada C, Rodman C, Ignacio G, Atala A, Almeida-Porada G Front Pharmacol. 2015; 5:276.

PMID: 25566073 PMC: 4263089. DOI: 10.3389/fphar.2014.00276.